In a population-based cohort of boys with Duchenne or Becker muscular dystrophy, deletions were the most common mutation, and the use of muscle biopsy for diagnosis declined over time.
Answers are grounded in this paper and cite their sources.
Supports genetic-first diagnosis in DMD/BMD; extends population-based mutation data but leaves biopsy role open for prospective study.
The type and frequency of diagnostic testing was analyzed in a population-based cohort of boys with Duchenne muscular dystrophy or Becker muscular dystrophy. Use of muscle biopsy declined from 66.0% of boys born between January 1982 and September 1987 to 32.6% born between April 1999 and September 2004. DMD mutation was documented for 345 (73.4%) boys. Deletions were more common and point mutations were less common than that has been reported in specialty clinic or laboratory-based cohorts. Deletion of one or more exons was detected in 270 individuals (57.4% of all patients and 78.3% with a DMD mutation). Duplication was identified in 39 individuals (8.3% of all patients and 11.3% with a DMD mutation). Point mutation, small insertion, or small deletion was found in 36 individuals (7.7% of all patients and 10.4% with a DMD mutation). Point mutation analysis was performed in only 37 of 130 (28.5%) individuals with negative deletion and/or duplication testing.
No takes yet. Share an insight, caveat, or question.
Cunniff et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: